SDTM Workflow Transformation: Faster, Easier and More Reliable

1 minute read

Published: November 14th, 2025

The demand for rapid, cost-effective, and standards-compliant SDTM delivery continues to increase across the biotech and pharmaceutical industry. While company level SDTM standards and SAS macro-based solutions have fulfilled the needs for many years, they can still be restrictive and less adaptable in today’s evolving trial landscape and performance requirements. 

This webinar series will discuss the practical needs on SDTM generation, the new expectation of SDTM automation, and how those would transform the workflow and purpose for a Statistics and Programming unit in pharma or CRO companies.

Speakers:
  • Liam Sheehan, Head of Programming
  • Lu Zhang, Associate Director of Programming
  • John McDade, Associate Director of Operational Excellence
Learning Points:
  • The new gold standard for SDTM automation and service.
  • Utilization of AI and open-source resources in SDTM automation.
  • The new possibilities/applications with the enhanced SDTM solution.
Complete the form below to access the recording and slides:

Related articles

From Data to Decisions: TMLE, Doubly Robust Methods, and Federated Learning

From Data to Decisions: TMLE, Doubly Robust Methods, and Federated Learning

March 17th, 2026 2 minute read

Join us for the second installment in our series on advanced causal methods for evidence-based decision-making. This ...

Causal Inference in Real World Evidence: What is it? Why now?

Causal Inference in Real World Evidence: What is it? Why now?

January 22nd, 2026 1 minute read

Causal inference is increasingly used to generate real-world evidence (RWE), by regulatory&n...

Regulatory-Grade Use of External Data: Bayesian Borrowing, Hybrid Trials and External Controls 

Regulatory-Grade Use of External Data: Bayesian Borrowing, Hybrid Trials and External Controls 

November 20th, 2025 1 minute read

Use of external data to augment clinical trials has been increasingly evaluated and is transforming drug development ...